WASHINGTON -- Corvas International Inc.'s largest shareholder Monday urged the company to cancel its proposed merger with Dendreon Corp. of Seattle, saying it isn't fair to shareholders and may not be ...
Company outlines its strategy for exploiting the serine protease gene family for new solid tumor cancer therapies at ACS Meeting Chicago, IL - August 27, 2001 - Corvas International, Inc. (Nasdaq: ...
Dendreon Corp. said it has completed its acquisition of fellow biotech company Corvas International Inc. in a stock deal valued at about $80 million. In February, Seattle-based Dendreon announced ...
Following missed endpoints discovered in preliminary analyses made public in April, Corvas International Inc. said late Friday that Pfizer Inc. would not develop Corvas' anti-inflammatory product any ...
Much of Nutt's work at Merck involved antithrombosis and antiinflammatory research. Among the drug candidates she developed is an anticlotting drug, GPIIb/IIIa antagonist, now in clinical trials. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results